- Home
- AMRN vs TEAF Comparison
AMRN vs TEAF Comparison
Compare AMRN & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- TEAF
- Stock Information
- Founded
- AMRN 1989
- TEAF 2017
- Country
- AMRN Ireland
- TEAF United States
- Employees
- AMRN N/A
- TEAF N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- TEAF Trusts Except Educational Religious and Charitable
- Sector
- AMRN Health Care
- TEAF Finance
- Exchange
- AMRN Nasdaq
- TEAF Nasdaq
- Market Cap
- AMRN 216.0M
- TEAF 163.0M
- IPO Year
- AMRN 1993
- TEAF N/A
- Fundamental
- Price
- AMRN $16.40
- TEAF $12.29
- Analyst Decision
- AMRN Strong Sell
- TEAF
- Analyst Count
- AMRN 1
- TEAF 0
- Target Price
- AMRN $12.00
- TEAF N/A
- AVG Volume (30 Days)
- AMRN 189.4K
- TEAF 56.1K
- Earning Date
- AMRN 07-30-2025
- TEAF 01-01-0001
- Dividend Yield
- AMRN N/A
- TEAF 9.20%
- EPS Growth
- AMRN N/A
- TEAF N/A
- EPS
- AMRN N/A
- TEAF N/A
- Revenue
- AMRN $214,112,000.00
- TEAF N/A
- Revenue This Year
- AMRN N/A
- TEAF N/A
- Revenue Next Year
- AMRN $7.88
- TEAF N/A
- P/E Ratio
- AMRN N/A
- TEAF N/A
- Revenue Growth
- AMRN N/A
- TEAF N/A
- 52 Week Low
- AMRN $7.08
- TEAF $11.11
- 52 Week High
- AMRN $17.18
- TEAF $13.30
- Technical
- Relative Strength Index (RSI)
- AMRN 72.83
- TEAF 71.72
- Support Level
- AMRN $15.78
- TEAF $12.19
- Resistance Level
- AMRN $17.18
- TEAF $12.28
- Average True Range (ATR)
- AMRN 0.96
- TEAF 0.12
- MACD
- AMRN 0.21
- TEAF 0.03
- Stochastic Oscillator
- AMRN 86.99
- TEAF 95.15
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About TEAF Ecofin Sustainable and Social Impact Term Fund
Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.